The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it ...

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

Abbott’s trial arrives in the wake of a growing IVL market. Johnson & Johnson has a FDA-approved technology, gaining access to the Shockwave systems through a $13.1bn acquisition of Shockwave Medical ...

Abbott (ABT) announced that the U.S. Food and Drug Administration, FDA, has approved an investigational device exemption, IDE, for its Coronary ...

A life cycle assessment, verified by the IVL Swedish Environmental Research Institute, demonstrates the advantages of Metsä ...

Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease: Abbott Park, Illinois Wednesday, March 26, 2025, 15:00 Hrs [IST] Ab ...

Boston Scientific announced via social media that it has closed the acquisition of Bolt Medical, which recently gained FDA ...

The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s coronary intravascular lithotripsy (IVL) system in a clinical trial.